Home
GANX
GANX News

Latest Gain Therapeutics Inc. (GANX) News on September 7, 2024

Gain Therapeutics to Participate at H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

5 days ago

Gain Therapeutics to Participate at H.C. Wainwright 26th Annual Global Investment Conference

Gain Therapeutics reports positive data from Phase I Parkinson’s treatment trial

Clinical Trials Arena

9 days ago

Gain Therapeutics reports positive data from Phase I Parkinson’s treatment trial

MT Newswires

9 days ago

Gain Therapeutics Says Phase 1 Data Confirm Safety of Parkinson's Disease Drug Candidate

Gain Therapeutics Announces Positive Topline Results from the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson’s Disease

GlobeNewswire

9 days ago

Gain Therapeutics Announces Positive Topline Results from the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson’s Disease

MT Newswires

24 days ago

Oppenheimer Adjusts Gain Therapeutics Price Target to $8 From $9

Gain Therapeutics Reports Financial Results for Second Quarter 2024 and Provides Corporate Update

GlobeNewswire

a month ago

Gain Therapeutics Reports Financial Results for Second Quarter 2024 and Provides Corporate Update

Gain Therapeutics to Participate at BTIG Virtual Biotechnology Conference

GlobeNewswire

a month ago

Gain Therapeutics to Participate at BTIG Virtual Biotechnology Conference

Gain Therapeutics Announces the Completion of Dosing in the Multiple Ascending Dose (MAD) of the Phase 1 Study of GT-02287, a Novel Small Molecule Therapy for Parkinson’s Disease

GlobeNewswire

2 months ago

Gain Therapeutics Announces the Completion of Dosing in the Multiple Ascending Dose (MAD) of the Phase 1 Study of GT-02287, a Novel Small Molecule Therapy for Parkinson’s Disease

Gain Therapeutics (GANX) Upgraded to Buy: Here's Why

Zacks

2 months ago

Gain Therapeutics (GANX) Upgraded to Buy: Here's Why

MT Newswires

2 months ago

HC Wainwright Trims Price Target on Gain Therapeutics to $8 From $9, Maintains Buy Rating

Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024

GlobeNewswire

2 months ago

Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024

MT Newswires

2 months ago

Gain Therapeutics Names Gene Mack as Interim Chief Executive Officer

Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO

GlobeNewswire

2 months ago

Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO

Gain Therapeutics Presents GT-02287 Data at Federation of European Neuroscience Societies (FENS) Forum 2024 Demonstrating Improvements in Cognitive Performance in a Preclinical Model of GBA1 Parkinson’s disease

GlobeNewswire

2 months ago

Gain Therapeutics Presents GT-02287 Data at Federation of European Neuroscience Societies (FENS) Forum 2024 Demonstrating Improvements in Cognitive Performance in a Preclinical Model of GBA1 Parkinson’s disease

Gain Therapeutics to Participate at H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

GlobeNewswire

2 months ago

Gain Therapeutics to Participate at H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

MT Newswires

3 months ago

Top Midday Decliners

MT Newswires

3 months ago

Gain Therapeutics Shares Tumble After Company Prices $11.0 Million Public Offering

MT Newswires

3 months ago

Top Premarket Decliners

Gain Therapeutics Announces Pricing of $11.0 Million Public Offering

GlobeNewswire

3 months ago

Gain Therapeutics Announces Pricing of $11.0 Million Public Offering

MT Newswires

3 months ago

Gain Therapeutics Plans Common Stock Offering to Finance Treatment for Neurodegenerative Disorders; Shares Fall After Hours

Gain Therapeutics Announces Proposed Public Offering

GlobeNewswire

3 months ago

Gain Therapeutics Announces Proposed Public Offering

Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Poster Presentation at Federation of European Neuroscience Societies (FENS) Forum 2024

GlobeNewswire

3 months ago

Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Poster Presentation at Federation of European Neuroscience Societies (FENS) Forum 2024

Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update

GlobeNewswire

4 months ago

Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update

Will Gain Therapeutics, Inc. (GANX) Report Negative Q1 Earnings? What You Should Know

Zacks

4 months ago

Will Gain Therapeutics, Inc. (GANX) Report Negative Q1 Earnings? What You Should Know

Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson’s Disease

GlobeNewswire

4 months ago

Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson’s Disease

Here's Why Gain Therapeutics (GANX) Could be Great Choice for a Bottom Fisher

Zacks

5 months ago

Here's Why Gain Therapeutics (GANX) Could be Great Choice for a Bottom Fisher

Insiders are Piling into These 10 Healthcare Stocks in 2024

Insider Monkey

5 months ago

Insiders are Piling into These 10 Healthcare Stocks in 2024

Down -25.88% in 4 Weeks, Here's Why You Should You Buy the Dip in Gain Therapeutics (GANX)

Zacks

5 months ago

Down -25.88% in 4 Weeks, Here's Why You Should You Buy the Dip in Gain Therapeutics (GANX)

Alpine Immune Sciences (ALPN) Moves 10.4% Higher: Will This Strength Last?

Zacks

5 months ago

Alpine Immune Sciences (ALPN) Moves 10.4% Higher: Will This Strength Last?

Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Officer

GlobeNewswire

5 months ago

Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Officer

Director Jeffrey Riley Acquires 30,000 Shares of Gain Therapeutics Inc (GANX)

GuruFocus.com

5 months ago

Director Jeffrey Riley Acquires 30,000 Shares of Gain Therapeutics Inc (GANX)

Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Medical Officer

GlobeNewswire

5 months ago

Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Medical Officer

Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update

GlobeNewswire

5 months ago

Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update

Gain Therapeutics to Present at Public Ventures Discovery Day

GlobeNewswire

6 months ago

Gain Therapeutics to Present at Public Ventures Discovery Day

EXCLUSIVE: Gain Therapeutics Highlights Lead Program Data Showcasing Its Impact On Cellular Death For Treating Parkinson's Disease

Benzinga

6 months ago

EXCLUSIVE: Gain Therapeutics Highlights Lead Program Data Showcasing Its Impact On Cellular Death For Treating Parkinson's Disease

Gain Therapeutics Presents Data at the AD/PD™ 2024 Conference Demonstrating the Mechanism of Action of GT-02287, its Clinical Stage GCase Regulator for the Treatment of Parkinson’s Disease

GlobeNewswire

6 months ago

Gain Therapeutics Presents Data at the AD/PD™ 2024 Conference Demonstrating the Mechanism of Action of GT-02287, its Clinical Stage GCase Regulator for the Treatment of Parkinson’s Disease

Gain Therapeutics Announces the Initiation of the Multiple Ascending Dose (MAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-targeting Small Molecule Therapy for GBA1 Parkinson’s Disease

GlobeNewswire

6 months ago

Gain Therapeutics Announces the Initiation of the Multiple Ascending Dose (MAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-targeting Small Molecule Therapy for GBA1 Parkinson’s Disease

Gain Therapeutics Announces 2024 R&D Update on Parkinson’s Disease with KOL & Analyst Insight

GlobeNewswire

7 months ago

Gain Therapeutics Announces 2024 R&D Update on Parkinson’s Disease with KOL & Analyst Insight

UPDATE - Gain Therapeutics’ GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson’s Disease

GlobeNewswire

7 months ago

UPDATE - Gain Therapeutics’ GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson’s Disease

Gain Therapeutics’ GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson’s Disease

GlobeNewswire

7 months ago

Gain Therapeutics’ GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson’s Disease

Natural Health Trends to Report Fourth Quarter 2023 Financial Results on February 7th

GlobeNewswire

7 months ago

Natural Health Trends to Report Fourth Quarter 2023 Financial Results on February 7th

Gain Therapeutics’ CEO Matthias Alder Issues Letter to Shareholders and Provides Operational Update

GlobeNewswire

7 months ago

Gain Therapeutics’ CEO Matthias Alder Issues Letter to Shareholders and Provides Operational Update

3 Penny Stocks to Turn $999 Into $1 Million: January 2024

InvestorPlace

7 months ago

3 Penny Stocks to Turn $999 Into $1 Million: January 2024

Semper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on Nasdaq

GlobeNewswire

7 months ago

Semper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on Nasdaq

Gain Therapeutics, Inc. (GANX) Upgraded to Strong Buy: Here's What You Should Know

Zacks

7 months ago

Gain Therapeutics, Inc. (GANX) Upgraded to Strong Buy: Here's What You Should Know

Travere (TVTX) Stock Up More Than 30% in 3 Months: Here's Why

Zacks

7 months ago

Travere (TVTX) Stock Up More Than 30% in 3 Months: Here's Why

CCSC Technology International Holdings Limited Announces Closing of Initial Public Offering

GlobeNewswire

8 months ago

CCSC Technology International Holdings Limited Announces Closing of Initial Public Offering

Shareholders in Southside Bancshares (NASDAQ:SBSI) are in the red if they invested a year ago

Simply Wall St.

8 months ago

Shareholders in Southside Bancshares (NASDAQ:SBSI) are in the red if they invested a year ago

Fidelity D & D Bancorp, Inc. First Quarter 2024 Dividend

GlobeNewswire

8 months ago

Fidelity D & D Bancorp, Inc. First Quarter 2024 Dividend

7 A-Rated Software Stocks to Buy in January

InvestorPlace

8 months ago

7 A-Rated Software Stocks to Buy in January

Vast Announces Appointment of Two Additional Directors to its Recently Expanded Board of Directors

Business Wire

8 months ago

Vast Announces Appointment of Two Additional Directors to its Recently Expanded Board of Directors

Is Lakeland Industries (LAKE) a Solid Growth Stock? 3 Reasons to Think "Yes"

Zacks

8 months ago

Is Lakeland Industries (LAKE) a Solid Growth Stock? 3 Reasons to Think "Yes"

Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to February 9, 2024

GlobeNewswire

8 months ago

Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to February 9, 2024

Fenbo Holdings Limited Announces Appointment of Mr. Meng Derong as Co-Chairman and Independent Non-Executive Director

GlobeNewswire

8 months ago

Fenbo Holdings Limited Announces Appointment of Mr. Meng Derong as Co-Chairman and Independent Non-Executive Director

How BankFinancial (BFIN) Stock Stands Out in a Strong Industry

Zacks

8 months ago

How BankFinancial (BFIN) Stock Stands Out in a Strong Industry

Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Platform Presentation at the 20th Annual WORLDSymposium™ 2024

GlobeNewswire

8 months ago

Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Platform Presentation at the 20th Annual WORLDSymposium™ 2024

Chimerix Appoints Lisa Decker to Board of Directors

GlobeNewswire

8 months ago

Chimerix Appoints Lisa Decker to Board of Directors

Peoples Bancorp of North Carolina, Inc.'s (NASDAQ:PEBK) market cap touched US$167m last week, benefiting both individual investors who own 43% as well as institutions

Simply Wall St.

8 months ago

Peoples Bancorp of North Carolina, Inc.'s (NASDAQ:PEBK) market cap touched US$167m last week, benefiting both individual investors who own 43% as well as institutions

Investors in Natural Health Trends (NASDAQ:NHTC) have unfortunately lost 49% over the last five years

Simply Wall St.

9 months ago

Investors in Natural Health Trends (NASDAQ:NHTC) have unfortunately lost 49% over the last five years

Taylor Devices (NASDAQ:TAYD) Shareholders Will Want The ROCE Trajectory To Continue

Simply Wall St.

9 months ago

Taylor Devices (NASDAQ:TAYD) Shareholders Will Want The ROCE Trajectory To Continue

Bears are Losing Control Over Gain Therapeutics, Inc. (GANX), Here's Why It's a 'Buy' Now

Zacks

9 months ago

Bears are Losing Control Over Gain Therapeutics, Inc. (GANX), Here's Why It's a 'Buy' Now

Positive Signs As Multiple Insiders Buy Chimerix Stock

Simply Wall St.

9 months ago

Positive Signs As Multiple Insiders Buy Chimerix Stock

Gabelli Global Utility & Income Trust Adds June 26, 2024 as Put Date for Series B Preferred Shares

GlobeNewswire

9 months ago

Gabelli Global Utility & Income Trust Adds June 26, 2024 as Put Date for Series B Preferred Shares

Purple Announces Positive Black Friday/Cyber Monday Weekend Selling Period and Reiterates 2023 Full Year Outlook Ahead of Investor Conferences

PR Newswire

9 months ago

Purple Announces Positive Black Friday/Cyber Monday Weekend Selling Period and Reiterates 2023 Full Year Outlook Ahead of Investor Conferences

Gain Therapeutics to Participate in FORCE Family Office Event with Zacks Small-Cap Research

GlobeNewswire

9 months ago

Gain Therapeutics to Participate in FORCE Family Office Event with Zacks Small-Cap Research

Gain Therapeutics Announces Preclinical Data Showing Restoration of Enzymatic Function with Novel Allosteric Regulators in GM1 Gangliosidosis Model

GlobeNewswire

9 months ago

Gain Therapeutics Announces Preclinical Data Showing Restoration of Enzymatic Function with Novel Allosteric Regulators in GM1 Gangliosidosis Model

Gain Therapeutics to Participate in AI Driven Drug Discovery Summit

GlobeNewswire

9 months ago

Gain Therapeutics to Participate in AI Driven Drug Discovery Summit

Smart Share Global Limited (NASDAQ:EM) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Smart Share Global Limited (NASDAQ:EM) Q3 2023 Earnings Call Transcript

Gain Therapeutics Announces Closing of $10.1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option

GlobeNewswire

9 months ago

Gain Therapeutics Announces Closing of $10.1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option

Gabelli Global Utility & Income Trust Alerts Series B Preferred Shareholders of Upcoming Put Date on December 26, 2023

GlobeNewswire

10 months ago

Gabelli Global Utility & Income Trust Alerts Series B Preferred Shareholders of Upcoming Put Date on December 26, 2023

PepGen Announces Appointment of Howard Mayer, M.D. to Board of Directors

GlobeNewswire

10 months ago

PepGen Announces Appointment of Howard Mayer, M.D. to Board of Directors

Purple Introduces Two New Pillows That Offer Deeper Sleep Through Customization and Portability

PR Newswire

10 months ago

Purple Introduces Two New Pillows That Offer Deeper Sleep Through Customization and Portability

Purple Innovation, Inc. (NASDAQ:PRPL) Q3 2023 Earnings Call Transcript

Insider Monkey

10 months ago

Purple Innovation, Inc. (NASDAQ:PRPL) Q3 2023 Earnings Call Transcript

Down -26.73% in 4 Weeks, Here's Why Eagle Pharmaceuticals (EGRX) Looks Ripe for a Turnaround

Zacks

10 months ago

Down -26.73% in 4 Weeks, Here's Why Eagle Pharmaceuticals (EGRX) Looks Ripe for a Turnaround

Clarus Corporation (NASDAQ:CLAR) Q3 2023 Earnings Call Transcript

Insider Monkey

10 months ago

Clarus Corporation (NASDAQ:CLAR) Q3 2023 Earnings Call Transcript

Prelude Therapeutics Insiders Are Down US$149k But Regain Some Losses

Simply Wall St.

10 months ago

Prelude Therapeutics Insiders Are Down US$149k But Regain Some Losses

P3 Health Partners Schedules Third-Quarter 2023 Earnings Release and Conference Call

Business Wire

10 months ago

P3 Health Partners Schedules Third-Quarter 2023 Earnings Release and Conference Call

Thomson Reuters StreetEvents

10 months ago

Q3 2023 Abcellera Biologics Inc Earnings Call

GuruFocus.com

10 months ago

Shore Bancshares Inc (SHBI) Reports Q3 2023 Net Loss of $6.4 Million Due to Merger Activity

Prelude Therapeutics Inc (PRLD) Reports Q3 Financial Results and Strategic Pipeline Progress

GuruFocus.com

10 months ago

Prelude Therapeutics Inc (PRLD) Reports Q3 Financial Results and Strategic Pipeline Progress

Natural Health Trends Corp. (NASDAQ:NHTC) Q3 2023 Earnings Call Transcript

Insider Monkey

10 months ago

Natural Health Trends Corp. (NASDAQ:NHTC) Q3 2023 Earnings Call Transcript

Prelude Announces Strategic Pipeline Progress and Updates, including its Partnership with AbCellera, and Reports Third Quarter Financial Results

GlobeNewswire

10 months ago

Prelude Announces Strategic Pipeline Progress and Updates, including its Partnership with AbCellera, and Reports Third Quarter Financial Results

Associated Press Finance

10 months ago

Shore Bancshares: Q3 Earnings Snapshot

Associated Press Finance

10 months ago

Territorial Bancorp: Q3 Earnings Snapshot

Territorial Bancorp Inc. Declares Dividend

GlobeNewswire

10 months ago

Territorial Bancorp Inc. Declares Dividend

Share on Social Networks: